A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus
Recruiting
Phase 1
Interventional Study
Diabetes Mellitus, Type 2
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The main objective of this trial is to assess the safety and tolerability of AMG 127 as single dose and multiple doses in healthy participants and participants with type 2 diabetes mellitus (T2DM).
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria for Part A and B
* Participant must be 18-65 years of age
* Participant must be overtly healthy
Inclusion Criteria for Part C
* Participant must be 40-75 years of age
* Confirmed diagnoses of T2DM
Exclusion Criteria for Part A and B
* History of hypotension, syncope, or ortho…
Contacts